Drug-labels.com

Envarsus Pa: Uses, Side Effects and Dosage

Status:
Prescription (Rx) Facts
Strength:
0.75 mg, 1 mg, 4 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Envarsus Pa

What is ENVARSUS PA used for?

ENVARSUS PA is used in adults who have had a kidney or a liver transplant to help prevent organ rejection. It is used along with other medicines.

How does ENVARSUS PA work?

Your immune system protects your body from infections and foreign materials. When you receive a transplant, your immune system will try to reject it. ENVARSUS PA is an immunosuppressant that blocks some parts of your immune system and helps your body accept a transplanted organ.

ENVARSUS PA is a prolonged-release tablet and is not the same as tacrolimus extended-release capsules or tacrolimus immediate-release capsules. Your healthcare professional should decide which medicine is right for you.

What are the ingredients in ENVARSUS PA?

Medicinal ingredient: tacrolimus

Non-medicinal ingredients: butylated hydroxytoluene, dimethicone, hypromellose, lactose monohydrate, magnesium stearate, poloxamer 188, polyethylene glycol, tartaric acid

ENVARSUS PA comes in the following dosage forms:

Tablets: 0.75 mg, 1 mg and 4 mg

Do not use ENVARSUS PA if you:

  • are allergic to tacrolimus.

Serious Warnings and Precautions

  • ENVARSUS PA may increase your chances of getting serious infections and some kinds of cancer, like skin cancer and lymphoma. These may lead to hospitalization or death.
  • ENVARSUS PA should only be prescribed by healthcare professionals who have experience in the use of immunosuppressive (anti-rejection) drugs and the management of organ transplants.
  • are allergic to any of the other ingredients in this medication or to a component of the container.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take ENVARSUS PA. Talk about any health conditions or problems you may have, including if you:

  • have a hereditary problem of galactose intolerance, such as the Lapp lactase deficiency or glucose-galactose malabsorption
  • have or have had a heart problem, such as heart failure, arrhythmia, congenital or acquired QT prolongation
  • have or have had high blood pressure called hypertension
  • have or have had kidney or liver problems
  • have any infections
  • have swelling or edema
  • have or have had diarrhea
  • have hepatitis

Other warnings you should know about:

New onset diabetes: ENVARSUS PA may cause new onset diabetes. Your healthcare professional may order tests to monitor your blood glucose levels.

Skin protection: You should limit your exposure to the sun and ultraviolet (UV) light while taking ENVARSUS PA. This is because immunosuppressants can increase the risk of skin cancer. You must wear appropriate protective clothing and use a sunscreen with a high sun protection factor (SPF 30 or higher). Your healthcare professional might examine your skin for any changes while taking ENVARSUS PA.

Vaccinations: You should not receive any vaccine while using ENVARSUS PA. Tell your healthcare professional if you have had or are scheduled to have any vaccinations.

Pregnancy and breastfeeding: If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, do not use this medicine unless advised by your healthcare professional. It is not known if it will harm your unborn baby. ENVARSUS PA can pass into your breast milk and may harm your baby.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with ENVARSUS PA:

  • Alcohol
  • Medicines used for irregular heart rhythm, such as amiodarone
  • Medicines used for bacterial infections, such as clarithromycin, chloramphenicol and erythromycin
  • Medicines used to control seizures and/or epilepsy, such as phenytoin, carbamazepine and phenobarbital
  • Medicines used to treat nausea and vomiting, such as metoclopramide • Medicines used for tuberculosis such as rifampin and rifabutin
  • Medicines used for fungal infections such as clotrimazole, fluconazole, voriconazole, posaconazole, itraconazole, ketoconazole, isavuconazole and caspofungin
  • Medicines used to treat inflammations or suppress the immune system (e.g., in transplant rejection), such as methylprednisolone and prednisone
  • Grapefruit and grapefruit juice
  • Medicines used to treat stomach disorders, such as cimetidine, lansoprazole, omeprazole and antacids (e.g., magnesium and aluminum hydroxide antacids)
  • Medicines used to treat HIV infection, such as ritonavir, nelfinavir and cobicistat
  • Hormone treatments, including contraceptive pills, such as danazol and ethinyl estradiol
  • Medicines called calcium channel blockers used to treat high blood pressure, such as verapamil, diltiazem and nifedipine
  • Nirmatrelvir /ritonavir, a medicine used to treat coronavirus disease 2019 (COVID-19)
  • Letermovir, a medicine used to treat cytomegalovirus (CMV) infections
  • Sirolimus or everolimus, medicines used to avoid rejection of the kidney transplant
  • Nilotinib, a medicine used to treat certain cancers
  • St John’s Wort, an herbal product used to treat depression
  • Schisandra sphenanthera extracts, an herbal product with various uses
  • Cannabidiol (CBD), an active ingredient in cannabis (marijuana) used to treat various medical conditions and also used for recreation
  • Nabilone, used to treat chemotherapy side effects
  • Nabiximols, used to help treat multiple sclerosis (MS) symptoms

How to take ENVARSUS PA:

Make sure that you receive the same tacrolimus medicine every time you collect your treatment, unless your healthcare professional changed it to a different tacrolimus medicine.

Speak to your pharmacist as soon as possible to make sure that you have the right product:

  • if the appearance of your medicine is not the same as usual;
  • if dose instructions have changed, or;
  • if the brand name is different.
  • Take ENVARSUS PA exactly as your healthcare professional tells you to.
  • Swallow the tablets whole with fluid (preferably with water).
  • Do not chew, divide or crush the tablets before swallowing. If you cannot swallow ENVARSUS PA tablets whole, talk to your healthcare professional.
  • Take the tablets once a day at the same time each day. It is best to take it in the morning.
  • It is recommended to take your medicine at least 1 hour before or 2 hours after a meal.

  • If your healthcare professional decides to switch your current tacrolimus medicine to ENVARSUS PA, continue taking your medication with meals, if you were doing so.
  • Stopping your treatment may increase the risk of rejection of your transplanted organ. Do not stop your treatment unless your healthcare professional tells you to do so.

Usual dose:

Your healthcare professional will tell you how many tablets to take. Your healthcare professional may change your dose if needed. Do not stop taking ENVARSUS PA or change your dose without talking to your healthcare professional.

Overdose:

If you think you, or a person you are caring for, have taken too much ENVARSUS PA, contact a healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

If you miss your dose of ENVARSUS PA, take it as soon as possible on the same day. Take your regular dose the next morning as usual. Never take two doses to make up for a forgotten dose.

What are possible side effects from using ENVARSUS PA?

These are not all the possible side effects you may have when taking ENVARSUS PA. If you experience any side effects not listed here, tell your healthcare professional.

Common side effects may include:

  • anxiety
  • constipation
  • edema (swelling) of the legs and arms
  • insomnia
  • tremor (shaking), especially of the hands

ENVARSUS PA can cause abnormal blood test results. Your healthcare professional may perform blood tests and will interpret the results.

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalGet immediate medical help
Only if severeIn all cases
VERY COMMON
Anemia (decreased red blood cells): dizziness, fainting, fatigue, feeling unwell, lack of energy, pale skin, pale stool, rapid heartbeat, shortness of breath, weakness✓
Diabetes (high blood sugar): blurred vision, confusion, drowsiness, frequent urination, fruity smell on your breath, increased thirst and hunger, loss of appetite, nausea, stomach pain or vomiting✓
Hypertension (high blood pressure): usually without symptoms but can appear as altered vision, dizziness, fainting, headache, head feeling “light”, tinnitus (buzzing or hissing in the ears), vertigo✓
Infections of urinary tract: frequent urination, pain or burning sensation when urinating, pain or pressure in lower back or abdomen, urine not looking or smelling normal✓
Leukopenia (decreased white blood cells): aches, fatigue, fever, infections, mouth ulcers, pains and flu-like symptoms, sweating✓
Liver problem: back pain, yellowing of the skin or eyes✓
Kidney problem: back and abdominal pain, change in the colour of urine (pale or dark), less urine produced, pain or discomfort when urinating, swelling of the legs and ankles✓
COMMON
Electrolyte disturbance (high/low blood levels of calcium, magnesium and/or phosphate): dehydration, diarrhea, eating disorders, vomiting✓
Infections of upper respiratory tract (sinus, nose, throat): common cold symptoms, cough, facial pain or pressure, fever, headache, nasal congestion, runny or stuffy nose, sneezing, sore throat✓
UNCOMMON
Thrombotic microangiopathy (serious blood vessel problems): fever, bruising under the skin that may appear as red dots, tiredness, confusion, yellowing of the skin or eyes, reduced urination✓
RARE / UNKNOWN
Cancer: new or abnormal mole on the skin, patch on the skin that doesn’t heal, or is itchy, bleeds or oozes, size or shape of an existing mole, skin ulcers (broken skin with an open wound), appearance of lumps in your breast or other areas of the body, a nagging cough or hoarseness, persistent and severe headaches, swollen lymph nodes, a change in your bladder or bowel habits✓
Gastrointestinal perforation (a hole in your stomach or bowels): chills or fever, nausea, severe abdominal pain, vomiting✓
Heart problems: abnormal heart rhythms, chest pain, dizziness, fainting, low or no pulse, nausea, pain irradiating in the arm, neck or back, palpitations, short breath, sweating✓
Optic neuropathy (problem with the nerves in your eye): change or loss of vision✓
Posterior encephalopathy syndrome (a nervous system disorder): change in mental state, coma, confusion, numbness and tingling, headache, seizures, vision changes✓
Progressive multifocal leukoencephalopathy (PML) (rare brain infection): changes in thinking, clumsiness of limbs, confusion, disturbance of vision, progressive weakness on one side of the body, memory and orientation, personality changes✓
Pure red cell aplasia (PCRA) (bone marrow stops producing red cells): dizziness, fainting, fatigue, feeling unwell, pale skin, pale stools, rapid heartbeat, shortness of breath, weakness✓
Respiratory distress: chest pain, difficulty to breathe, short breath✓
Sepsis: confusion, fever, low body temperature, rapid breathing, rapid heart rate, swelling✓

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (canada.ca/drug-device-reporting) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

  • Store ENVARSUS PA between 15°C-25°C, protect from light.
  • Keep out of reach and sight of children.

If you want more information about ENVARSUS PA:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); manufacturer’s website (https://knighttx.com), by emailing

    medinfo@knighttx.com, or by calling 1-844-483-5636.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02485877

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Envarsus Pa

Rx or OTC
Prescription (Rx)?
DIN 02485877, 02485885, 02485893
Schedule(s) PRESCRIPTION
Active ingredient(s) Tacrolimus
Dosage form(s) Tablet (Extended-Release)
Route(s) of administration Oral
Drug class (WHO ATC)
  1. L Antineoplastic and immunomodulating agents
    1. L04 Immunosuppressants
      1. L04A Immunosuppressants
        1. L04AD Calcineurin inhibitors
          1. L04AD02 Tacrolimus
Company KNIGHT THERAPEUTICS INC.
Current status Marketed
Current status date March 23, 2026
Strengths and forms
DIN Strength Dosage form(s) Current status
02485877 0.75 MG Tablet (Extended-Release) Marketed March 23, 2026
02485885 1 MG Tablet (Extended-Release) Marketed March 23, 2026
02485893 4 MG Tablet (Extended-Release) Marketed March 23, 2026

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.